跳至主要内容
临床试验/JPRN-jRCTs031230041
JPRN-jRCTs031230041进行中(未招募)Unknown

A Clinical Study on the Efficacy and Safety of a New Method of Fecal Microbiota Transplantation (FMT) for Treatment of Autism Spectrum Disorder (ASD)

Tanaka Yoshimu0 个研究点目标入组 30 人开始时间: 2023年4月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 5age old 至 <= 12age old(—)
性别
All

入选标准

  • 1. Children between the ages of 5 and 12,
  • regardless of gender, who have recently been
  • diagnosed with ASD by a board-certified pediatric
  • neurologist of The Japanese Society of Child
  • Neurology, a board-certified psychiatrist of
  • The Japanese Society for Psychiatry and Neurology,
  • a board-certified member of The Japanese Society
  • for Child and Adolescent Psychiatry, or a
  • board-certified member of Japanese Society of
  • Pediatric Psychiatry and Neurology.
  • 2. Generally good physical health aside from
  • gastrointestinal problems.
  • 3. Children who are able to give informed assent
  • to take part in the clinical study.
  • 4. Children who are able to obtain informed
  • consent from their legally authorized
  • representatives to take part in the clinical study.

排除标准

  • 1. Currently on treatment with medicines.
  • 2. Received antibiotics (excluding topical
  • antibiotics) within the last three months.
  • 3. Received fecal microbiota transplantation
  • within the last 12 months.
  • 4. Children with a single gene disorder
  • (Fragile X, Rett Syndrome, Joubert Syndrome,
  • etc. which may affect the evaluation of ASD).
  • 5. Children with neurosurgical or neurological
  • 6. Currently on tube feeding.
  • 7. Severely underweight and malnourished
  • less than 65% of a standard body weight.
  • 8. Had surgery within the last 12 months or
  • are scheduled to have surgery within the
  • next six months.
  • 9. Current participation in other clinical trials.
  • 10. Children who are judged by a principal
  • investigator to be unsuitable for other reasons.

研究者

发起方
Tanaka Yoshimu

相似试验